Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Kian Behbakht

Concepts (451)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Ovarian Neoplasms
44
2025
487
5.540
 Why?
Poly(ADP-ribose) Polymerase Inhibitors
8
2024
90
1.310
 Why?
Peritoneal Neoplasms
7
2024
87
1.130
 Why?
Endometrial Neoplasms
10
2019
164
1.050
 Why?
Drug Resistance, Neoplasm
16
2024
744
1.000
 Why?
Antineoplastic Combined Chemotherapy Protocols
9
2020
1558
0.970
 Why?
Uterine Cervical Neoplasms
8
2017
232
0.930
 Why?
Genital Neoplasms, Female
6
2020
81
0.930
 Why?
Cystadenocarcinoma, Serous
6
2024
68
0.850
 Why?
Hysterectomy
4
2018
118
0.770
 Why?
Antineoplastic Agents
10
2023
2041
0.750
 Why?
Fallopian Tube Neoplasms
6
2024
15
0.730
 Why?
TNF-Related Apoptosis-Inducing Ligand
5
2017
43
0.670
 Why?
Biomarkers, Tumor
8
2019
1175
0.630
 Why?
Gelatin
2
2016
40
0.620
 Why?
Neoplasms, Glandular and Epithelial
3
2015
35
0.600
 Why?
Models, Economic
1
2018
53
0.590
 Why?
Thrombin
2
2016
143
0.590
 Why?
Claudin-4
4
2025
15
0.570
 Why?
Hyperthermia, Induced
1
2018
108
0.560
 Why?
Female
84
2025
68017
0.530
 Why?
Pelvic Infection
1
2016
4
0.520
 Why?
Cell Line, Tumor
20
2025
3168
0.520
 Why?
Homeodomain Proteins
3
2012
489
0.520
 Why?
Tissue Adhesives
1
2016
17
0.520
 Why?
Cost-Benefit Analysis
1
2018
567
0.490
 Why?
Neoplastic Cells, Circulating
2
2017
70
0.490
 Why?
Women
1
2015
52
0.460
 Why?
Sirolimus
2
2016
189
0.460
 Why?
Neoplasm Recurrence, Local
6
2019
955
0.450
 Why?
Vagina
6
2016
175
0.420
 Why?
Health Knowledge, Attitudes, Practice
2
2015
1272
0.390
 Why?
Antibodies, Neoplasm
1
2012
35
0.390
 Why?
Neoplasm Staging
15
2024
1288
0.380
 Why?
Humans
88
2025
128020
0.380
 Why?
Middle Aged
47
2024
30813
0.380
 Why?
Cisplatin
2
2015
297
0.370
 Why?
Histone-Lysine N-Methyltransferase
2
2024
125
0.350
 Why?
Aged
35
2024
21892
0.330
 Why?
Neoadjuvant Therapy
4
2020
381
0.330
 Why?
Robotic Surgical Procedures
3
2016
109
0.330
 Why?
Pelvic Exenteration
1
2009
11
0.330
 Why?
Apoptosis
8
2019
2425
0.330
 Why?
Leiomyosarcoma
3
2020
27
0.320
 Why?
Uterine Neoplasms
4
2019
102
0.320
 Why?
Paclitaxel
3
2019
213
0.320
 Why?
Phthalazines
2
2019
40
0.320
 Why?
Cytoreduction Surgical Procedures
2
2020
61
0.320
 Why?
Receptors, TNF-Related Apoptosis-Inducing Ligand
3
2017
29
0.310
 Why?
Aged, 80 and over
17
2020
7029
0.310
 Why?
Pyrimidines
3
2019
446
0.310
 Why?
Health Personnel
1
2015
645
0.310
 Why?
Tumor Microenvironment
2
2024
620
0.310
 Why?
Carcinoma, Endometrioid
3
2019
47
0.300
 Why?
Chemotherapy, Adjuvant
2
2020
377
0.300
 Why?
Caffeine
1
2008
61
0.290
 Why?
Carbazoles
1
2008
84
0.290
 Why?
Azepines
2
2019
88
0.290
 Why?
Clinical Competence
1
2015
1007
0.290
 Why?
Papanicolaou Test
2
2004
42
0.280
 Why?
Vaginal Smears
2
2004
56
0.280
 Why?
Piperazines
2
2019
332
0.270
 Why?
Postoperative Complications
6
2020
2456
0.270
 Why?
Protein Kinase C
1
2008
255
0.270
 Why?
Gene Expression Regulation, Neoplastic
7
2025
1343
0.260
 Why?
Adult
29
2020
35177
0.250
 Why?
Hemostasis, Surgical
2
2016
19
0.240
 Why?
Laparotomy
2
2015
106
0.230
 Why?
Adenocarcinoma
4
2015
888
0.230
 Why?
Urban Health
1
2004
79
0.230
 Why?
Genomic Instability
1
2025
47
0.230
 Why?
Disease-Free Survival
7
2017
647
0.230
 Why?
Fallopian Tubes
1
2024
30
0.220
 Why?
Prognosis
9
2024
3766
0.210
 Why?
Histocompatibility Antigens
2
2024
107
0.210
 Why?
Pyrazoles
2
2020
401
0.210
 Why?
Genetic Therapy
2
2014
290
0.210
 Why?
Uterine Cervical Dysplasia
2
2003
43
0.200
 Why?
Adenocarcinoma, Clear Cell
2
2021
14
0.200
 Why?
Neoplasm Grading
5
2024
283
0.190
 Why?
Leiomyoma
2
2019
74
0.190
 Why?
Hospitals, Public
1
2001
26
0.180
 Why?
Healthcare Disparities
2
2018
579
0.180
 Why?
BRCA2 Protein
3
2019
53
0.180
 Why?
Piperidines
2
2019
190
0.180
 Why?
Hospitals, University
1
2001
176
0.170
 Why?
Vulvar Neoplasms
1
2020
11
0.170
 Why?
Treatment Outcome
11
2020
10110
0.170
 Why?
Cervix Uteri
3
2011
50
0.170
 Why?
Mutation
5
2019
3682
0.170
 Why?
Epoxy Compounds
1
2020
32
0.170
 Why?
Carnitine O-Palmitoyltransferase
1
2020
45
0.170
 Why?
Rad51 Recombinase
1
2019
12
0.160
 Why?
Cell Movement
2
2016
933
0.160
 Why?
Enoxaparin
1
2020
58
0.160
 Why?
Up-Regulation
2
2020
822
0.160
 Why?
Neoplasms
4
2017
2460
0.160
 Why?
Vaccines, Conjugate
1
2019
63
0.160
 Why?
Receptors, Adiponectin
1
2019
19
0.160
 Why?
Poly(ADP-ribose) Polymerases
1
2019
87
0.160
 Why?
Interleukin-12
2
2014
118
0.150
 Why?
Sequence Analysis, RNA
2
2019
427
0.150
 Why?
CD8-Positive T-Lymphocytes
1
2024
840
0.150
 Why?
Pyridones
1
2020
158
0.150
 Why?
Patient Acceptance of Health Care
1
2004
756
0.150
 Why?
Lymph Node Excision
2
2020
164
0.150
 Why?
Adjuvants, Immunologic
1
2019
221
0.150
 Why?
Cancer Vaccines
1
2019
163
0.150
 Why?
Sarcoma
1
2020
176
0.150
 Why?
Ovariectomy
2
2015
136
0.150
 Why?
Cost Savings
1
2018
78
0.150
 Why?
Oncologists
1
2018
35
0.150
 Why?
Cell Growth Processes
2
2008
52
0.140
 Why?
Breast Neoplasms
4
2019
2131
0.140
 Why?
Dose-Response Relationship, Drug
4
2008
1943
0.140
 Why?
Pregnancy Complications, Infectious
1
2002
363
0.140
 Why?
Aurora Kinase A
1
2017
55
0.140
 Why?
Antineoplastic Agents, Phytogenic
1
2019
185
0.140
 Why?
Leukocyte Common Antigens
1
2017
81
0.140
 Why?
beta Catenin
1
2019
217
0.140
 Why?
Fatty Acids
1
2020
415
0.140
 Why?
Anion Transport Proteins
1
2017
8
0.140
 Why?
Survival Rate
5
2020
1870
0.140
 Why?
Salpingectomy
2
2015
13
0.130
 Why?
Sexual Dysfunctions, Psychological
1
2017
34
0.130
 Why?
Gestational Trophoblastic Disease
1
2016
5
0.130
 Why?
Curettage
1
2016
8
0.130
 Why?
Animals
13
2024
34487
0.130
 Why?
Keratins
1
2017
175
0.130
 Why?
Megestrol Acetate
1
2016
2
0.130
 Why?
Carcinoma, Neuroendocrine
1
2016
32
0.130
 Why?
Risk Factors
6
2016
9696
0.130
 Why?
Sexual Dysfunction, Physiological
1
2017
67
0.130
 Why?
Minority Groups
1
2018
250
0.130
 Why?
Venous Thromboembolism
1
2020
271
0.130
 Why?
Neoplasms, Squamous Cell
1
1996
4
0.130
 Why?
Colony Count, Microbial
1
2016
114
0.130
 Why?
Standard of Care
1
2016
72
0.130
 Why?
Medroxyprogesterone Acetate
1
2015
35
0.130
 Why?
Adenoviridae
1
1996
189
0.130
 Why?
Gynecology
1
2018
175
0.130
 Why?
Brachytherapy
1
2016
104
0.130
 Why?
Gene Expression Profiling
2
2019
1681
0.120
 Why?
Cell Survival
4
2025
1073
0.120
 Why?
Anticoagulants
1
2020
615
0.120
 Why?
Keratin-5
1
2015
49
0.120
 Why?
Molecular Targeted Therapy
1
2018
384
0.120
 Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2017
940
0.120
 Why?
Tretinoin
1
1996
127
0.120
 Why?
Tamoxifen
1
2016
200
0.120
 Why?
Chemoradiotherapy
1
2016
209
0.120
 Why?
Mice
9
2024
16574
0.120
 Why?
Immunohistochemistry
3
2016
1663
0.120
 Why?
Combined Modality Therapy
4
2020
1199
0.120
 Why?
Antineoplastic Agents, Hormonal
1
2015
158
0.120
 Why?
CA-125 Antigen
2
2008
15
0.110
 Why?
Abdominal Abscess
1
2014
26
0.110
 Why?
Surgeons
1
2018
259
0.110
 Why?
Mice, SCID
2
2012
350
0.110
 Why?
Reoperation
1
2016
541
0.110
 Why?
Kaplan-Meier Estimate
4
2020
851
0.110
 Why?
Immunotherapy
1
2018
586
0.110
 Why?
Lipid Metabolism
1
2017
491
0.110
 Why?
Endometrium
1
2014
61
0.110
 Why?
Glycoproteins
1
2015
337
0.110
 Why?
Cytokines
1
2002
1984
0.110
 Why?
Cell Cycle
2
2025
580
0.110
 Why?
Quality of Health Care
1
2018
605
0.110
 Why?
Interpersonal Relations
1
2017
388
0.110
 Why?
Transforming Growth Factor beta
1
1996
443
0.110
 Why?
Proto-Oncogene Proteins c-akt
2
2016
419
0.110
 Why?
Models, Biological
3
2019
1689
0.100
 Why?
Pelvic Neoplasms
1
2013
19
0.100
 Why?
Young Adult
5
2020
12282
0.100
 Why?
Antigens, CD
1
2015
481
0.100
 Why?
Genes, Tumor Suppressor
3
1998
86
0.100
 Why?
Plasmids
1
2014
354
0.100
 Why?
RNA, Messenger
2
2012
2669
0.100
 Why?
Escherichia coli
1
2016
766
0.100
 Why?
Gardnerella vaginalis
2
2002
4
0.100
 Why?
Antibody Specificity
1
2012
182
0.090
 Why?
Cell Division
2
2008
777
0.090
 Why?
Neoplastic Stem Cells
1
2015
377
0.090
 Why?
Endocrine Gland Neoplasms
1
2011
1
0.090
 Why?
Transplantation, Heterologous
1
2012
187
0.090
 Why?
RNA, Small Interfering
3
2020
569
0.090
 Why?
Cyclin D1
1
2011
63
0.090
 Why?
Drug Synergism
2
2011
356
0.090
 Why?
Proteasome Inhibitors
1
2011
42
0.090
 Why?
MicroRNAs
1
2017
674
0.090
 Why?
Adenocarcinoma, Mucinous
1
2011
75
0.090
 Why?
DNA
1
2017
1392
0.090
 Why?
Peptides
1
2015
910
0.090
 Why?
Transfection
2
2007
891
0.090
 Why?
Cell Proliferation
4
2019
2337
0.080
 Why?
Cadherins
1
2011
186
0.080
 Why?
Neoplasm Invasiveness
3
2016
477
0.080
 Why?
Lymphoma
1
2011
194
0.080
 Why?
Inflammation
1
2020
2646
0.080
 Why?
Age Factors
5
2016
3100
0.080
 Why?
Skin Transplantation
1
2009
84
0.080
 Why?
Anastomosis, Surgical
1
2009
149
0.080
 Why?
Adolescent
5
2020
20158
0.080
 Why?
Adaptor Proteins, Signal Transducing
1
2011
391
0.080
 Why?
Papillomaviridae
2
2002
113
0.080
 Why?
Urokinase-Type Plasminogen Activator
1
2008
29
0.080
 Why?
TOR Serine-Threonine Kinases
1
2011
380
0.080
 Why?
G2 Phase
1
2008
36
0.080
 Why?
Radiation-Protective Agents
1
2008
26
0.070
 Why?
Rectum
1
2009
169
0.070
 Why?
Case-Control Studies
4
2019
3324
0.070
 Why?
Models, Statistical
1
2011
621
0.070
 Why?
Heterografts
2
2019
128
0.070
 Why?
Genes, BRCA1
2
1998
32
0.070
 Why?
Class I Phosphatidylinositol 3-Kinases
2
2019
81
0.070
 Why?
Microsatellite Instability
2
2019
37
0.070
 Why?
Urinary Bladder
1
2009
175
0.070
 Why?
Cell Culture Techniques
2
2020
344
0.070
 Why?
Xenograft Model Antitumor Assays
2
2020
809
0.070
 Why?
Cysteine
1
2008
182
0.070
 Why?
Tumor Suppressor Protein p53
3
2019
504
0.070
 Why?
Gynecologic Surgical Procedures
2
2020
56
0.070
 Why?
PTEN Phosphohydrolase
2
2019
157
0.070
 Why?
Double-Blind Method
3
2019
1852
0.060
 Why?
Retrospective Studies
6
2020
14404
0.060
 Why?
Models, Animal
1
2008
365
0.060
 Why?
Proportional Hazards Models
3
2020
1194
0.060
 Why?
Adenosarcoma
2
2005
2
0.060
 Why?
Follow-Up Studies
4
2020
4853
0.060
 Why?
Signal Transduction
4
2012
4812
0.060
 Why?
Length of Stay
3
2015
1114
0.060
 Why?
Polymerase Chain Reaction
4
2002
1020
0.060
 Why?
Indazoles
2
2019
65
0.060
 Why?
Colposcopy
2
2003
16
0.060
 Why?
Intestinal Neoplasms
1
2005
27
0.060
 Why?
Ovary
1
2007
210
0.060
 Why?
Cell Count
2
2015
310
0.060
 Why?
Neoplasm Proteins
3
1998
419
0.060
 Why?
Germ-Line Mutation
2
1996
138
0.060
 Why?
United States
5
2022
13785
0.060
 Why?
Ultraviolet Rays
1
2008
378
0.060
 Why?
Sexual Behavior
1
2009
481
0.060
 Why?
Chicago
1
2004
57
0.060
 Why?
Disease Progression
3
2019
2598
0.060
 Why?
Tumor Cells, Cultured
2
1996
930
0.060
 Why?
Peptide Fragments
1
2008
688
0.060
 Why?
Antioxidants
1
2008
542
0.060
 Why?
Transcription Factors
4
2011
1628
0.060
 Why?
Blood Loss, Surgical
2
2015
90
0.060
 Why?
Survival Analysis
4
2020
1262
0.050
 Why?
Activating Transcription Factor 6
1
2023
17
0.050
 Why?
Receptors, Estrogen
2
2015
424
0.050
 Why?
Transcription Factor AP-1
1
2023
85
0.050
 Why?
X-ray Repair Cross Complementing Protein 1
1
2022
14
0.050
 Why?
Neoplasm Metastasis
2
2015
608
0.050
 Why?
Medical Oncology
1
2024
271
0.050
 Why?
Risk Assessment
3
2016
3223
0.050
 Why?
Vaginal Neoplasms
1
2001
12
0.050
 Why?
Trichomonas vaginalis
1
2002
13
0.050
 Why?
Phosphatidylinositol 3-Kinases
2
2016
356
0.050
 Why?
Gene Expression
1
2007
1454
0.050
 Why?
Yeasts
1
2002
53
0.050
 Why?
Vaginosis, Bacterial
1
2001
12
0.050
 Why?
Women's Health
1
2004
361
0.050
 Why?
Cell Nucleus
1
2025
579
0.050
 Why?
Vaginal Diseases
1
2001
22
0.050
 Why?
Pregnancy
3
2016
6355
0.050
 Why?
Endometriosis
1
2001
48
0.050
 Why?
DNA, Neoplasm
2
1998
159
0.040
 Why?
DNA Primers
1
2002
509
0.040
 Why?
Vulvectomy
1
2020
2
0.040
 Why?
Epithelial Cells
1
2007
1037
0.040
 Why?
Histiocytoma, Malignant Fibrous
1
2020
4
0.040
 Why?
Databases, Factual
2
2016
1264
0.040
 Why?
Dermatofibrosarcoma
1
2020
9
0.040
 Why?
Hospitals, Urban
1
2001
129
0.040
 Why?
Clinical Trials, Phase I as Topic
1
2020
50
0.040
 Why?
DNA Repair
1
2022
205
0.040
 Why?
Alleles
3
2017
842
0.040
 Why?
Medically Uninsured
1
2001
127
0.040
 Why?
Liposarcoma
1
2020
27
0.040
 Why?
Anoikis
1
2020
31
0.040
 Why?
Prospective Studies
4
2016
7035
0.040
 Why?
Hemocyanins
1
2019
62
0.040
 Why?
Interleukin-10
1
2002
298
0.040
 Why?
Diagnosis, Differential
2
2019
1408
0.040
 Why?
DNA Damage
1
2022
363
0.040
 Why?
Chitinase-3-Like Protein 1
1
2019
19
0.040
 Why?
Rhabdomyosarcoma
1
2020
64
0.040
 Why?
Logistic Models
1
2004
1975
0.040
 Why?
Radiotherapy
1
2020
185
0.040
 Why?
Enzyme-Linked Immunosorbent Assay
1
2002
815
0.040
 Why?
SEER Program
1
2020
206
0.040
 Why?
Neoplasms, Cystic, Mucinous, and Serous
1
2019
25
0.040
 Why?
Intramolecular Oxidoreductases
1
2019
62
0.040
 Why?
Lymphatic Metastasis
1
2020
317
0.040
 Why?
Poly-ADP-Ribose Binding Proteins
1
2019
33
0.040
 Why?
DNA Polymerase II
1
2019
38
0.040
 Why?
Gene Knockdown Techniques
1
2020
311
0.040
 Why?
Chromosomes, Human, Pair 7
1
1998
15
0.040
 Why?
Cell Cycle Checkpoints
1
2019
95
0.040
 Why?
Cytoskeletal Proteins
1
2019
143
0.040
 Why?
Mechanistic Target of Rapamycin Complex 1
1
2019
115
0.040
 Why?
Mitosis
1
2019
178
0.040
 Why?
Microtubule-Associated Proteins
1
2019
189
0.040
 Why?
Europe
1
2019
359
0.040
 Why?
AMP-Activated Protein Kinases
1
2019
189
0.040
 Why?
Interleukin-6
1
2002
712
0.040
 Why?
Interleukin-1
1
2002
949
0.040
 Why?
Colorectal Neoplasms, Hereditary Nonpolyposis
1
1998
33
0.040
 Why?
Wnt Signaling Pathway
1
2019
165
0.040
 Why?
Image Cytometry
1
2017
7
0.040
 Why?
Chromosomes, Human, Pair 14
1
1997
19
0.030
 Why?
Ganciclovir
1
1996
51
0.030
 Why?
Chromosome Deletion
1
1997
102
0.030
 Why?
Socioeconomic Factors
1
2001
1211
0.030
 Why?
Hospitals, Private
1
2016
12
0.030
 Why?
Health Facility Size
1
2016
11
0.030
 Why?
Mass Spectrometry
1
2019
662
0.030
 Why?
Oxidation-Reduction
1
2020
1001
0.030
 Why?
Time Factors
2
2019
6479
0.030
 Why?
Chorionic Gonadotropin
1
2016
80
0.030
 Why?
Indoles
1
2019
371
0.030
 Why?
Cell Differentiation
2
2011
1896
0.030
 Why?
Ifosfamide
1
1996
34
0.030
 Why?
AC133 Antigen
1
2015
18
0.030
 Why?
Cell Separation
1
2017
312
0.030
 Why?
Cell Line, Transformed
1
1996
140
0.030
 Why?
Marriage
1
2017
113
0.030
 Why?
Tissue Array Analysis
1
2015
57
0.030
 Why?
Hospital Charges
1
1996
41
0.030
 Why?
RNA-Binding Proteins
1
2019
388
0.030
 Why?
Hospitals, Teaching
1
2016
112
0.030
 Why?
Caspase 3
1
2016
229
0.030
 Why?
Cystadenocarcinoma, Papillary
1
1995
5
0.030
 Why?
Carboplatin
1
1996
140
0.030
 Why?
Cell Cycle Proteins
1
2019
578
0.030
 Why?
Tumor Burden
1
2016
283
0.030
 Why?
Disease Management
1
2019
583
0.030
 Why?
Ataxia Telangiectasia Mutated Proteins
1
2015
65
0.030
 Why?
DNA Mismatch Repair
1
2015
47
0.030
 Why?
Ileus
1
2015
12
0.030
 Why?
Genes, p53
1
1995
70
0.030
 Why?
Income
1
2016
189
0.030
 Why?
Urinary Retention
1
2015
20
0.030
 Why?
Elective Surgical Procedures
1
2016
162
0.030
 Why?
Female Urogenital Diseases
1
2014
5
0.030
 Why?
RNA Interference
1
2016
441
0.030
 Why?
Taxoids
1
2015
95
0.030
 Why?
Antigens, Neoplasm
1
2017
308
0.030
 Why?
Morbidity
1
2015
301
0.030
 Why?
Intraoperative Complications
1
2015
129
0.030
 Why?
Sensitivity and Specificity
1
2019
1813
0.030
 Why?
Receptors, Androgen
1
2015
143
0.030
 Why?
Multivariate Analysis
2
1996
1492
0.030
 Why?
Drug Administration Schedule
1
2016
755
0.030
 Why?
Histones
1
2019
585
0.030
 Why?
Reference Values
1
1996
776
0.030
 Why?
Blood Volume
1
2014
59
0.030
 Why?
Bevacizumab
1
2015
129
0.030
 Why?
Point Mutation
1
1995
221
0.030
 Why?
Bleomycin
1
1996
240
0.030
 Why?
Infusions, Parenteral
1
2014
38
0.030
 Why?
Polyethyleneimine
1
2014
18
0.030
 Why?
Hemostatics
1
2014
47
0.030
 Why?
Pelvis
1
2015
101
0.030
 Why?
DNA, Viral
1
1996
348
0.030
 Why?
Deoxycytidine
1
2015
163
0.030
 Why?
Insurance, Health
1
2016
267
0.030
 Why?
Tumor Suppressor Proteins
1
2016
313
0.030
 Why?
Receptors, Progesterone
1
2015
341
0.030
 Why?
Drainage
1
2014
165
0.030
 Why?
Anemia
1
2015
160
0.030
 Why?
Lipids
1
2017
619
0.030
 Why?
Preoperative Care
1
2015
335
0.030
 Why?
Urban Population
1
2016
440
0.030
 Why?
Thrombocytopenia
1
2015
184
0.030
 Why?
Gene Transfer Techniques
1
2014
162
0.030
 Why?
Referral and Consultation
1
2018
724
0.030
 Why?
Patient Readmission
1
2018
663
0.030
 Why?
Polymorphism, Single-Stranded Conformational
3
1998
28
0.030
 Why?
Membrane Proteins
1
2019
1105
0.030
 Why?
Ultrasonography
1
2016
708
0.030
 Why?
Biomarkers
1
2024
3874
0.020
 Why?
Linear Models
1
1994
816
0.020
 Why?
Rural Population
1
2016
511
0.020
 Why?
Cholesterol
1
2014
406
0.020
 Why?
Zinc Finger E-box-Binding Homeobox 1
1
2011
22
0.020
 Why?
Analysis of Variance
1
1994
1266
0.020
 Why?
Perioperative Period
1
2011
48
0.020
 Why?
Protein Kinase Inhibitors
1
2017
875
0.020
 Why?
Mutant Proteins
1
2011
99
0.020
 Why?
Comorbidity
1
2016
1537
0.020
 Why?
DNA Fragmentation
1
2011
43
0.020
 Why?
Risk Reduction Behavior
1
2013
208
0.020
 Why?
Fas Ligand Protein
1
2011
59
0.020
 Why?
Tomography, X-Ray Computed
2
2014
2509
0.020
 Why?
Hyperplasia
1
2011
170
0.020
 Why?
Neovascularization, Pathologic
1
2012
289
0.020
 Why?
Neoplasm Transplantation
1
2011
257
0.020
 Why?
Administration, Oral
1
2012
766
0.020
 Why?
Polymorphism, Single Nucleotide
1
2017
2059
0.020
 Why?
Antibodies, Monoclonal, Humanized
1
2015
754
0.020
 Why?
Epithelial-Mesenchymal Transition
1
2011
201
0.020
 Why?
Pregnancy Complications
1
2014
487
0.020
 Why?
Anti-Bacterial Agents
2
2014
1689
0.020
 Why?
Regression Analysis
1
2011
978
0.020
 Why?
Polyethylene Glycols
1
2014
598
0.020
 Why?
Receptors, Urokinase Plasminogen Activator
1
2008
14
0.020
 Why?
Patient Discharge
1
2015
850
0.020
 Why?
Quality of Life
1
2020
2672
0.020
 Why?
Injections, Subcutaneous
1
2008
145
0.020
 Why?
Blotting, Western
1
2011
1169
0.020
 Why?
Placebos
1
2008
201
0.020
 Why?
Mice, Hairless
1
2008
57
0.020
 Why?
Enzyme Inhibitors
1
2011
809
0.020
 Why?
Sulfonamides
1
2011
494
0.020
 Why?
Quality Improvement
1
2015
1093
0.020
 Why?
Molecular Sequence Data
3
1996
2820
0.020
 Why?
Chromosome Mapping
2
1998
504
0.020
 Why?
Genetic Markers
2
1998
338
0.020
 Why?
Disease Models, Animal
1
2016
3936
0.020
 Why?
Receptors, Cell Surface
1
2008
373
0.020
 Why?
Frameshift Mutation
2
1996
31
0.020
 Why?
Cross-Sectional Studies
1
2017
5034
0.020
 Why?
Gene Deletion
2
1998
369
0.020
 Why?
Carcinosarcoma
1
2005
17
0.020
 Why?
Cohort Studies
1
2015
5378
0.010
 Why?
DNA Mutational Analysis
2
1996
384
0.010
 Why?
Colorado
1
2014
4369
0.010
 Why?
Severity of Illness Index
1
2011
2703
0.010
 Why?
Obesity
1
2016
2859
0.010
 Why?
Base Sequence
2
1996
2134
0.010
 Why?
Electrophoresis, Gel, Pulsed-Field
1
2001
19
0.010
 Why?
Metronidazole
1
2001
20
0.010
 Why?
Genes, rRNA
1
2001
41
0.010
 Why?
Microbial Sensitivity Tests
1
2001
348
0.010
 Why?
DNA, Bacterial
1
2001
323
0.010
 Why?
RNA, Ribosomal, 16S
1
2001
519
0.010
 Why?
Loss of Heterozygosity
1
1998
46
0.010
 Why?
Microsatellite Repeats
1
1998
161
0.010
 Why?
Actuarial Analysis
1
1996
25
0.010
 Why?
Ecosystem
1
2001
563
0.010
 Why?
Genes, Neoplasm
1
1995
20
0.010
 Why?
BRCA1 Protein
1
1995
65
0.010
 Why?
Sequence Analysis, DNA
1
1998
771
0.010
 Why?
Age of Onset
1
1996
490
0.010
 Why?
Introns
1
1995
249
0.010
 Why?
Exons
1
1995
338
0.010
 Why?
Amino Acid Sequence
1
1995
2042
0.010
 Why?
Male
1
2017
62758
0.010
 Why?
Behbakht's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (451) concept(s)
_
Co-Authors Expand Description
See all (56) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)